-
One year of breast cancer in Ibadan, Southwestern Nigeria: a histopathological review
-
The expression status of human epidermal growth factor receptor 2 in epithelial ovarian cancer in Ibadan, Nigeria
-
The expression status of human epidermal growth factor receptor 2 in epithelial ovarian cancer in Ibadan, Nigeria
-
Radiosensitisation of low HER-2 expressing human breast cancer cell lines
-
Evaluation of small molecule inhibitors of HER2, PI3K, mTOR and Bcl-2 for their radiomodulatory effects in human breast cancer cell lines
-
Evaluation of the BCL-2, PI3K, PARP-1, and HSP90 pathways in breast, lung and glial cell lines for identification of candidate genes as therapeutic targets for overcoming radioresistance.
-
Immunohistochemical human epidermal growth factor receptor 2 (her2) expression pattern in gastric adenocarcinomas in a Nigerian tertiary hospital
-
Comparison of Xpert® Breast cancer STRAT4 assay and immunohistochemistry for the evaluation of breast cancer biomarkers in South African patients
-
The paracrine effects of fibroblasts on Doxorubicin-treated breast cancer cells
-
Prevalence of shoulder morbidity after treatment for breast cancer in South Africa
-
The assessment of T-cell subsets in response to treatment in patients with breast or oesophageal cancer
-
Barriers to and facilitators of adherence to intravenous chemotherapy among breast cancer patients at a tertiary hospital in the Western Cape
-
Treatment outcomes of young patients with invasive breast cancer treated radically at Groote Schuur Hospital from 2013-2017: A single centre study
-
Metabolic control analysis using glycolytic inhibitor titrations in the MCF-7 breast cancer cell line
-
Development and application of a pathology supported pharmacogenetic test for improved clinical management of South African patients with breast cancer and associated co-morbidities
-
Extended cost effectiveness analysis of interventions for early detection, screening and breast cancer control: case studies of South Africa and Uganda
-
Engineering carbon nanotubes as therapeutic nanocarriers of Tulbaghia violacea, Annona muricata, Dicoma capensis and Dodonaea viscosa plant-based extracts, targeting breast and colorectal cancer
-
Evaluating deep learning for enhanced breast cancer diagnosis: a comparative analysis of CNN architectures
-
Chemotherapy naive breast cancer: a correlation study between BD Cytorich™ Red cell blocks and formalin- fixed paraffinembedded tissue blocks
-
Phytoestrogenic extracts of Cyclopia modulate molecular targets involved in the prevention and treatment of breast cancer
-
Coping with breast cancer and mastectomy : a prospective study of the process
-
The role of the AHNAK protein in breast cancer : implications for tumour metastasis and chemoresistance
-
Exploring delays to help-seeking among patients presenting late for symptomatic breast cancer at Tygerberg Hospital.
-
A surveillance of estrogen receptor (er), progesterone receptor (pr) and human epidermal growth factor receptor-2 (her-2) status in malignant female breast lesions in Bayelsa state, Nigeria.
